(Q34063156)

30 July 2017

1 reference

title

Pharmacologic therapy of ventricular arrhythmias (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1103605

Cardiology and cardiovascular medicine

22 August 2022

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

22 September 2023

author name string

R. A. Winkle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1103605

22 August 2022

S. A. Glantz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1103605

22 August 2022

D. C. Harrison

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1103605

22 August 2022

language of work or name

English

0 references

publication date

1 October 1975

1 reference

30 July 2017

31 October 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1103605

full work available at URL

22 August 2022

https://api.elsevier.com/content/article/PII:0002914975901666?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

https://api.elsevier.com/content/article/PII:0002914975901666?httpAccept=text/plain

22 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

American Journal of Cardiology

22 September 2023

published in

1 reference

30 July 2017

volume

36

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

629-650

1 reference

Symposium on Electophysiologic Correlates of Clinical Arrhythmias. 3. Contribution of His bundle recordings to the understanding of clinical arrhythmias.

30 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Intracardiac Electrocardiography in the Analysis and Understanding of Cardiac Arrhythmias

22 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The His bundle electrogram

22 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Ambulatory long-term electrocardiography--the "LCG".

22 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men

22 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Relationship of premature systoles to coronary heart disease and sudden death in the Tecumseh epidemiologic study

22 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Prognostic significance of ventricular ectopic beats with respect to sudden death in the late postinfarction period

22 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Surgical treatment of refractory life-threatening ventricular tachycardia

22 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Life-threatening ventricular arrhythmias induced by exercise. Cessation after coronary bypass surgery.

22 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Control of Intractable Ventricular Tachycardia by Coronary Revascularization

22 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Reversible Cardiomyopathy Associated with Hemochromatosis

22 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Prospective correlative study of ventricular aneurysm. Mechanistic concept and clinical recognition

22 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Echocardiographic abnormalities in the mitral valve prolapse syndrome

22 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Percutaneous Transvenous Endomyocardial Biopsy

22 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Antiarrhythmic Drug Therapy for Sporadic Ventricular Ectopic Arrhythmias

22 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Disposition kinetics of lidocaine in normal subjects.

22 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

THE ANTIARRHYTHMIC PROPERTIES OF LIDOCAINE AND PROCAINE AMIDE. CLINICAL AND PHYSIOLOGIC STUDIES OF THEIR CARDIOVASCULAR EFFECTS IN MAN.

22 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Effect of Lidocaine on Ventricular Arrhythmias in Patients with Coronary Heart Disease

22 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Use of lignocaine in treatment of cardiac arrhythmias

22 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The Use of procaine amide and lidocaine in the treatment of cardiac arrhythmias

22 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man

22 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The convulsant potency of lidocaine and its N-dealkylated metabolites

22 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Identification of glycinexylidide in patients treated with intravenous lidocaine

22 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Pharmacokinetics of lidocaine in man

22 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man

22 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans

22 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Lidocaine disposition kinetics in monkey and man. II. Effects of hemorrhage and sympathomimetic drug administration

22 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Lidocaine metabolism in normal and phenobarbital-pretreated dogs.

22 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Cardiovascular effects of infusion of lidocaine on patients with heart disease.

22 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Hemodynamic effects of lidocaine in patients with heart disease.

22 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Atrioventricular block with lidocaine therapy

22 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Sinoatrial Arrest due to Lidocaine in a Patient Receiving Quinidine

22 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Sinus Standstill Following Intravenous Lidocaine Administration

22 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The effect of lidocaine on atrioventricular and intraventricular conduction in man

22 September 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Effect of lignocaine on conducting system of human heart

22 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Lidocaine-induced heart block in patients with bundle branch block

22 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Immediate effects of intravenous propranolol on various cardiac arrhythmias.

22 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The use of propranolol in arrhythmias complicating acute myocardial infarction

22 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications

22 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications

22 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias

22 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Plasma Propranolol Levels Associated with Suppression of Ventricular Ectopic Beats

22 September 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Plasma propranolol levels in adults With observations in four children

22 September 2023

53

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites

22 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Isopropylamine, a biologically active deamination product of propranolol in dogs: identification of deuterated and unlabeled isopropylamine by gas chromatography-mass spectrometry

22 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol

22 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey

22 September 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The almost complete hepatic extraction of propranolol during intravenous administration in the dog

22 September 2023

59

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The disposition of propranolol. I. Elimination during oral absorption in man

22 September 2023

60

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

22 September 2023

61

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

22 September 2023

62

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.

22 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.

22 September 2023

65

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Time Required for Complete Recovery from Chronic Propranolol Therapy

22 September 2023

66

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Relation of propranolol plasma level to beta-blockade during oral therapy

22 September 2023

68

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Pharmacodynamics of Propranolol in Renal Failure

22 September 2023

69

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program

22 September 2023

71

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Acute Organic Brain Syndrome with Propranolol

22 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Propranolol induced alopecia

22 September 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Peripheral arterial insufficiency. A complication of beta-adrenergic blocking therapy

22 September 2023

74

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Hypoglycaemia precipitated by propranolol

22 September 2023

75

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy.

22 September 2023

76

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Myocardial infarction after propranolol withdrawal

22 September 2023

77

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

22 September 2023

Procaine amide; a review

79

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Use of pronestyl in the treatment of ectopic rhythms; treatment of 98 episodes in 78 patients.

22 September 2023

80

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial Infarction

22 September 2023

81

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure

22 September 2023

82

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Procainamide Dosage Schedules, Plasma Concentrations, and Clinical Effects

22 September 2023

83

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Plasma concentration of procainamide and prevalence of exertional arrhythmias

22 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Pharmacokinetic of procainamide in man

22 September 2023

85

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Metabolism of procainamide in rhesus monkey and man

22 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Pharmacokinetics of Procainamide

22 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Value and hazards of intravenous procaine amide ("pronestyl") therapy.

22 September 2023

90

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Fatal ventricular fibrillation following procaine amide hydrochloride therapy; report of a case.

22 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The intramuscular use of pronestyl (Procaine amide).

22 September 2023

92

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose

22 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Hemodynamic changes following procaine amide administered intravenously.

22 September 2023

94

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Hemodynamic effects of procainamide in patients with acute myocardial infarction and comparison with lidocaine.

22 September 2023

95

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Electrophysiologic effects of procaine amide in patients with intraventricular conduction delay

22 September 2023

98

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The action of procaine amide in complete heart block.

22 September 2023

99

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Agranulocytosis following maintenance dosage of pronestyl; report of severe case with recovery.

22 September 2023

100

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Reversible procainamide-induced agranulocytosis twice in one patient

22 September 2023

101

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Procainamide-induced pericardial effusion

22 September 2023

103

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Antinuclear antibody induced by procainamide. A prospective study

22 September 2023

104

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The procainamide-induced lupus syndrome

22 September 2023

105

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Letter: Procainamide and acute arthritis.

22 September 2023

106

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Procainamide-induced lupus erythematosus. Clinical and laboratory observations

22 September 2023

107

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Relationship Between the Plasma Level of Diphenylhydantoin Sodium and Its Cardiac Antiarrhythmic Effects

22 September 2023

108

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

DIPHENYLHYDANTOIN SODIUM IN CARDIAC ARRHYTHMIAS

22 September 2023

109

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The current status of diphenylhydantoin in heart disease

22 September 2023

110

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Phenytoin in post-operative cardiac arrhythmias

22 September 2023

111

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Diphenylhydantoin in cardiac arrhythmias

22 September 2023

112

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Diphenylhydantoin in the Prevention of Recurring Ventricular Tachycardia

22 September 2023

113

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Metabolic disposition of diphenylhydantoin in normal human subiects following intravenous administration

22 September 2023

116

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY

22 September 2023

117

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.

22 September 2023

120

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation

22 September 2023

122

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The rate of decline of diphenylhydantoin in human plasma

22 September 2023

123

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Biochemical and genetic factors regulating dilantin metabolism in man.

22 September 2023

124

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

DIPHENYLHYDANTOIN AND PHENOBARBITAL TOXICITY. THE ROLE OF LIVER DISEASE

22 September 2023

125

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Acute diphenylhydantoin intoxication following halothane anesthesia.

22 September 2023

126

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Some Causes of Ineffectiveness of Diphenylhydantoin

22 September 2023

127

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Acute intoxication with 5,5-diphenylhydantoin (Dilantin) associated with impairment of biotransformation. Plasma levels and urinary metabolites; and studies in healthy volunteers.

22 September 2023

128

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Dicoumarol-induced diphenylhydantoin intoxication

22 September 2023

129

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Inhibition of drug metabolism by chloramphenicol

22 September 2023

130

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Inhibition of diphenylhydantoin metabolism by chloramphenicol

22 September 2023

131

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients

22 September 2023

132

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Interaction between phenytoin and the benzodiazepines

22 September 2023

133

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin. Excretion of HPPH in the urine

22 September 2023

134

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Phenytoin intoxication during treatment with antabuse (Disulfiram)

22 September 2023

135

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Diphenylhydantoin intoxication attendant to slow inactivation of isoniazid.

22 September 2023

137

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy

22 September 2023

138

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Methylphenidate Interaction With Both Anticonvulsants and Ethyl Biscoumacetate

22 September 2023

139

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The effect of phenyramidol on the metabolism of diphenylhydantoin

22 September 2023

140

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism.

22 September 2023

141

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man

22 September 2023

142

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Increased Rate of Clearance of Drugs from the Circulation of Alcoholics*

22 September 2023

143

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution

22 September 2023

144

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The Alteration of Plasma Proteins in Uremia as Reflected in their Ability to Bind Digitoxin and Diphenylhydantoin

22 September 2023

145

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

22 September 2023

146

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Abnormal pharmacokinetics of phenytoin in a patient with uraemia

22 September 2023

147

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Copper deficiency in a premature infant fed on iron-fortified formula

22 September 2023

148

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Diphenylhydantoin Metabolism in Uremia

22 September 2023

149

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Diphenylhydantoin side effects and serum albumin levels

22 September 2023

150

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants

22 September 2023

151

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Inadequate serum levels after intramuscular administration of diphenylhydantoin

22 September 2023

152

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin

22 September 2023

153

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

A method for estimation of plasma diphenylhydantoin concentration

22 September 2023

154

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The metabolism of diphenylhydantoin (Dilantin(R)) following once-daily administration

22 September 2023

156

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Outbreak of Anticonvulsant Intoxication in an Australian City

22 September 2023

158

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Fatalities following intravenous use of sodium diphenylhydantoin for cardiac arrhythmias. Report of two cases

22 September 2023

159

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Fatal Ventricular Fibrillation Following Intravenous Sodium Diphenylhydantoin Therapy

22 September 2023

160

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Ventricular standstill after intravenous diphenylhydantoin

22 September 2023

161

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Fatal Results From Diphenylhydantoin Administered Intravenously

22 September 2023

162

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Cardiac and peripheral vascular effects of diphenylhydantoin sodium

22 September 2023

163

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The hemodynamic effects of diphenylhydantoin.

22 September 2023

164

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Effect of Diphenylhydantoin on Left Ventricular Function in Patients with Heart Disease

22 September 2023

165

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Effects of Diphenylhydantoin on Atrioventricular Conduction in Man

22 September 2023

166

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Electrophysiologic Properties of Diphenylhydantoin

22 September 2023

167

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Dangerous consequence from use of phenytoin in atrial flutter

22 September 2023

168

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The effect of diphenylhydantoin on atrioventricular and intraventricular conduction in man

22 September 2023

169

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Intoxication with 5,5-diphenylhydantoin (Dilantin): clinical features, blood levels, urinary metabolites, and metabolic changes in a child

22 September 2023

171

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

DIPHENYLHYDANTOIN ACTIVATED SEIZURES

22 September 2023

172

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The present status of therapy of the cardiac arrhythmias with quinidine

22 September 2023

173

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Quinidine for prophylaxis of arrhythmias in acute myocardial infarction

22 September 2023

174

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Quinidine Elimination in Patients with Congestive Heart Failure or Poor Renal Function

22 September 2023

177

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Influence of disease on binding of drugs to plasma proteins

22 September 2023

178

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Some quantitative aspects of the binding of quinidine and related quinoline compounds by human serum albumin

22 September 2023

179

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT

22 September 2023

181

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Quinidine Excretion in Aciduria and Alkaluria

22 September 2023

182

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Comparison of two methods for quinidine determination and chromatographic analysis of the difference

22 September 2023

184

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

22 September 2023

187

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Some quantitative aspects of treatment with quinidine

22 September 2023

189

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The electrophysiological effects of intramuscular guinidine on the atrioventricular conducting system in man

22 September 2023

191

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Quinidine toxicity and its treatment. An Experimental study

22 September 2023

192

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The influence of quinidine and procaine amide on myocardial contractility in vivo

22 September 2023

193

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Some effects of quinidine sulfate on the heart and circulation in man

22 September 2023

194

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Quinidine Fever: An Unusual Manifestation of Quinidine Allergy

22 September 2023

196

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Quinidine purpura: report of six cases

22 September 2023

197

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Quinidine-induced liver disease

22 September 2023

198

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Hemolytic anemia due to quinidine: observations on its mechanism

22 September 2023

199

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Antiarrhythmic and circulatory effects of Astra W36095, a new lidocaine-like agent.

22 September 2023

200

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Evaluation of lidocaine resistance in man using intermittent large-dose infusion techniques.

22 September 2023

202

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Evaluation of propranolol and quinidine in the treatment of quinidine-resistant arrhythmias

22 September 2023

203

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Haemodynamic Changes Following Separate and Combined Administration of Beta‐Blocking Drugs and Quinidine*

22 September 2023

204

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Hemodynamic interaction of procainamide and lidocaine after experimental myocardial infarction.

22 September 2023

205

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

The use of ventricular pacing for suppression of ectopic ventricular activity

22 September 2023

206

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

Chronic overdrive pacing in the control of refractory ventricular arrhythmias.

22 September 2023

207

1 reference

https://api.crossref.org/works/10.1016/0002-9149(75)90166-6

22 September 2023

Identifiers

1 reference

30 July 2017

1 reference